We are live on ! Find out more
JAG

Journey Advisory Group Portfolio holdings

AUM $1.17B
1-Year Est. Return 20.21%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+20.21%
3 Year Est. Return
+58.66%
5 Year Est. Return
+76.52%
10 Year Est. Return
–
AUM
$286M
AUM Growth
+$18.6M
Cap. Flow
+$9.11M
Cap. Flow %
3.19%
Top 10 Hldgs %
33.12%
Holding
195
New
15
Increased
80
Reduced
61
Closed
1

Top Buys

Rank Stock Value
1
BLK icon
Blackrock
BLK
+$1.46M
2
BND icon
Vanguard Total Bond Market
BND
+$998K
3
MSFT icon
Microsoft
MSFT
+$995K
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$570K
5
QQQ icon
Invesco QQQ Trust
QQQ
+$562K

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$1.79M
2
SLV icon
iShares Silver Trust
SLV
+$907K
3
T icon
AT&T
T
+$439K
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$325K
5
CLIX icon
ProShares Long Online/Short Stores ETF
CLIX
+$216K

Sector Composition

Rank Sector Weight
1 Technology 15.33%
2 Healthcare 9.83%
3 Consumer Staples 8.8%
4 Financials 7.67%
5 Industrials 6.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEP icon
26
PepsiCo
PEP
$191B
$2.93M 1.02%
20,708
+714
+4% +$98K
SCHR
27
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$2.81M 0.98%
99,464
-2,914
-3% -$83.6K
BLK icon
28
Blackrock
BLK
$164B
$2.66M 0.93%
3,529
+2,013
+133% +$1.46M
HUM icon
29
Humana
HUM
$46.1B
$2.62M 0.92%
6,250
+100
+2% +$39.9K
SLV icon
30
iShares Silver Trust
SLV
$28.3B
$2.59M 0.91%
114,260
-37,250
-25% -$907K
EW icon
31
Edwards Lifesciences
EW
$48.2B
$2.45M 0.86%
29,339
-190
-0.6% -$16.1K
IBB icon
32
iShares Biotechnology ETF
IBB
$9.49B
$2.31M 0.81%
15,339
+444
+3% +$70.5K
FDX icon
33
FedEx
FDX
$74B
$2.24M 0.78%
7,897
+200
+3% +$51.5K
CB icon
34
Chubb
CB
$139B
$2.22M 0.78%
14,063
-31
-0.2% -$5K
PGX icon
35
Invesco Preferred ETF
PGX
$3.8B
$2.2M 0.77%
146,372
+1,289
+0.9% +$19.2K
DUK icon
36
Duke Energy
DUK
$101B
$2.19M 0.77%
22,702
-341
-1% -$31.1K
VZ icon
37
Verizon
VZ
$198B
$2.03M 0.71%
34,978
-63
-0.2% -$3.56K
XOM icon
38
ExxonMobil
XOM
$640B
$1.99M 0.7%
35,628
-1,091
-3% -$57.2K
PFE icon
39
Pfizer
PFE
$141B
$1.98M 0.69%
54,671
+3
+0% +$107
CCI icon
40
Crown Castle
CCI
$32.7B
$1.98M 0.69%
11,492
+1,161
+11% +$186K
MRK icon
41
Merck
MRK
$324B
$1.97M 0.69%
26,795
+5
+0% +$369
CSX icon
42
CSX Corp
CSX
$95.8B
$1.96M 0.69%
61,011
– –
BRK.A icon
43
Berkshire Hathaway Class A
BRK.A
$1.07T
$1.93M 0.67%
5
– –
INTC icon
44
Intel
INTC
$453B
$1.9M 0.66%
29,700
+1
+0% +$60
TJX icon
45
TJX Companies
TJX
$173B
$1.78M 0.62%
26,921
-1
-0% -$67
NOC icon
46
Northrop Grumman
NOC
$78B
$1.76M 0.62%
5,454
– –
GOOGL icon
47
Alphabet (Google) Class A
GOOGL
$3.99T
$1.74M 0.61%
16,820
+540
+3% +$53.3K
CLX icon
48
Clorox
CLX
$11.7B
$1.69M 0.59%
8,758
+209
+2% +$40.2K
MMM icon
49
3M
MMM
$91.2B
$1.69M 0.59%
10,466
-137
-1% -$20.5K
ABBV icon
50
AbbVie
ABBV
$458B
$1.67M 0.59%
15,461
+536
+4% +$57.3K
1
2
3 4 5

Similar funds

TFA
Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
BBCM
Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.18B AUM 28.15% 1-Year Est. Return
MTC
McDaniel Terry & Co Austin, Texas $1.18B AUM 16.46% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
OCAI
O'Connor Alternative Investments New York $1.17B AUM
OWSCM
One William Street Capital Management New York $1.18B AUM 38% 1-Year Est. Return

Journey Advisory Group's Q1 2021 Portfolio in Review

As of Q1 2021, Journey Advisory Group held 195 positions worth $286M, up 7% from $267M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Journey Advisory Group deployed $9.11M of net new capital in Q1 2021, opening 15 new positions and adding to 80 existing holdings. Its largest new stake was Lam Research: 8,210 shares worth $489K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was US Bancorp, an estimated $1.79M trimmed.

  • Journey Advisory Group's largest Q1 2021 buy was Lam Research: 8,210 shares worth $489K.
  • Journey Advisory Group added most to Blackrock in Q1 2021, an estimated $1.46M increase.
  • Journey Advisory Group's biggest Q1 2021 reduction was US Bancorp, cutting an estimated $1.79M.
  • Journey Advisory Group fully exited ProShares Long Online/Short Stores ETF in Q1 2021, selling an estimated $216K.
  • Journey Advisory Group's ten largest holdings make up 33% of its $286M portfolio in Q1 2021.
  • Journey Advisory Group opened 15 new positions and closed 1 in Q1 2021.
  • Journey Advisory Group's portfolio value rose 7% quarter-over-quarter to $286M.

Based on Journey Advisory Group's 13F filing for Q1 2021, filed 11 May 2021.